KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Cash & Current Investments: 2009-2025

Historic Cash & Current Investments for Bausch Health Companies (BHC) over the last 17 years, with Sep 2025 value amounting to $1.3 billion.

  • Bausch Health Companies' Cash & Current Investments rose 78.67% to $1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.4 billion, marking a year-over-year increase of 76.08%. This contributed to the annual value of $1.2 billion for FY2024, which is 24.84% up from last year.
  • Latest data reveals that Bausch Health Companies reported Cash & Current Investments of $1.3 billion as of Q3 2025, which was down 23.12% from $1.7 billion recorded in Q2 2025.
  • In the past 5 years, Bausch Health Companies' Cash & Current Investments ranged from a high of $2.5 billion in Q1 2022 and a low of $497.0 million during Q3 2022.
  • Over the past 3 years, Bausch Health Companies' median Cash & Current Investments value was $780.0 million (recorded in 2023), while the average stood at $948.2 million.
  • Per our database at Business Quant, Bausch Health Companies' Cash & Current Investments plummeted by 78.41% in 2023 and then surged by 179.78% in 2025.
  • Bausch Health Companies' Cash & Current Investments (Quarterly) stood at $582.0 million in 2021, then rose by 1.55% to $591.0 million in 2022, then surged by 62.77% to $962.0 million in 2023, then climbed by 24.84% to $1.2 billion in 2024, then spiked by 78.67% to $1.3 billion in 2025.
  • Its last three reported values are $1.3 billion in Q3 2025, $1.7 billion for Q2 2025, and $1.2 billion during Q1 2025.